20 µg versus> 20 µg estrogen combined oral contraceptives for contraception

MF Gallo, K Nanda, DA Grimes… - Cochrane Database …, 2013 - cochranelibrary.com
Background Concern about estrogen‐related adverse effects has led to progressive
reductions in the estrogen dose in combination oral contraceptives (COCs). However …
被引用次数：274 相关文章

20 µg versus> 20 µg estrogen combined oral contraceptives for contraception.

MF Gallo, K Nanda, DA Grimes, LM Lopez… - … Cochrane Database of …, 2013 - europepmc.org
Background Concern about estrogen-related adverse effects has led to progressive
reductions in the estrogen dose in combination oral contraceptives (COCs). However …
[HTML] nih.gov

[HTML][HTML] 20 µg versus> 20 µg estrogen combined oral contraceptives for contraception

MF Gallo, K Nanda, DA Grimes, LM Lopez… - … Cochrane Database of …, 2013 - ncbi.nlm.nih.gov
Background Concern about estrogen‐related adverse effects has led to progressive
reductions in the estrogen dose in combination oral contraceptives (COCs). However …

20 µg versus> 20 µg estrogen combined oral contraceptives for contraception

MF Gallo, K Nanda, DA Grimes… - Cochrane Database …, 2011 - cochranelibrary.com
Background Concern about estrogen‐related adverse effects has led to progressive
reductions in the estrogen dose in combination oral contraceptives (COCs). However …

20 microg versus> 20 microg estrogen combined oral contraceptives for contraception

MF Gallo, K Nanda, DA Grimes… - The Cochrane …, 2008 - pubmed.ncbi.nlm.nih.gov
Background Concern about estrogen-related adverse effects has led to progressive
reductions in the estrogen dose in combination oral contraceptives (COCs). However …
[HTML] epa.gov

[HTML][HTML] 20 µg versus> 20 µg estrogen combined oral contraceptives for contraception

MF Gallo, K Nanda, DA Grimes, LM Lopez… - Cochrane Database of …, 2013 - hero.epa.gov
BACKGROUND: Concern about estrogen-related adverse effects has led to progressive
reductions in the estrogen dose in combination oral contraceptives (COCs). However …

20 µg versus> 20 µg estrogen combined oral contraceptives for contraception.

MF Gallo, K Nanda, DA Grimes, LM Lopez… - … Cochrane Database of …, 2011 - europepmc.org
Background Concern about estrogen-related adverse effects has led to progressive
reductions in the estrogen dose in combination oral contraceptives (COCs). However …

20 microg versus> 20 microg estrogen combined oral contraceptives for contraception

MF Gallo, K Nanda, DA Grimes, LM Lopez… - Cochrane Database of …, 2008 - hero.epa.gov
BACKGROUND: Concern about estrogen-related adverse effects has led to progressive
reductions in the estrogen dose in combination oral contraceptives (COCs). However …

20 µg versus> 20 µg estrogen combined oral contraceptives for contraception

MF Gallo, K Nanda, DA Grimes… - The Cochrane …, 2013 - pubmed.ncbi.nlm.nih.gov
Background Concern about estrogen-related adverse effects has led to progressive
reductions in the estrogen dose in combination oral contraceptives (COCs). However …